Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Fairlie

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Drug Design and Discovery|January 1, 1993
Designing metalloinhibitors for delivery to peptide receptors in enzymesD P Fairlie
Biochimica Et Biophysica Acta|November 15, 1995
Hydroxyquinones are competitive non-peptide inhibitors of HIV-1 proteinaseR I Brinkworth, D P Fairlie
Current Medicinal Chemistry|May 29, 2001
Macrocycles mimic the extended peptide conformation recognized by aspartic, serine, cysteine and metallo proteasesJ D Tyndall, D P Fairlie
Agents and Actions. Supplements|January 1, 1981
cis-Platinum(II) amines: toxicities and immunosuppressant/anti-arthritic activitiesD P Fairlie, M W Whitehouse
Biochemical and Biophysical Research Communications|October 30, 1992
Non-peptidic anti-AIDS agents: inhibition of HIV-1 proteinase by disulfonatesR I Brinkworth, D P Fairlie
Journal of Molecular Recognition : JMR|December 28, 1999
Conformational homogeneity in molecular recognition by proteolytic enzymesJ D Tyndall, D P Fairlie
Biochemical Pharmacology|March 15, 1982
Lymphoid suppression by cis-platinum(II) amines. What are the active agents?D P Fairlie, M W Whitehouse
Trends in Pharmacological Sciences|February 1, 1995
Targeting HIV-1 protease: a test of drug-design methodologiesM L West, D P Fairlie
Drug Design and Discovery|December 1, 1991
Transdermal delivery of inorganic complexes as metal drugs or nutritional supplementsD P Fairlie, M W Whitehouse
Current Opinion in Drug Discovery & Development|August 4, 2009
Macrocyclic peptidomimetics: potential for drug developmentR P McGeary, D P Fairlie
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Drug Design and Discovery|January 1, 1993
Designing metalloinhibitors for delivery to peptide receptors in enzymesD P Fairlie
Biochimica Et Biophysica Acta|November 15, 1995
Hydroxyquinones are competitive non-peptide inhibitors of HIV-1 proteinaseR I Brinkworth, D P Fairlie
Current Medicinal Chemistry|May 29, 2001
Macrocycles mimic the extended peptide conformation recognized by aspartic, serine, cysteine and metallo proteasesJ D Tyndall, D P Fairlie
Agents and Actions. Supplements|January 1, 1981
cis-Platinum(II) amines: toxicities and immunosuppressant/anti-arthritic activitiesD P Fairlie, M W Whitehouse
Biochemical and Biophysical Research Communications|October 30, 1992
Non-peptidic anti-AIDS agents: inhibition of HIV-1 proteinase by disulfonatesR I Brinkworth, D P Fairlie
Journal of Molecular Recognition : JMR|December 28, 1999
Conformational homogeneity in molecular recognition by proteolytic enzymesJ D Tyndall, D P Fairlie
Biochemical Pharmacology|March 15, 1982
Lymphoid suppression by cis-platinum(II) amines. What are the active agents?D P Fairlie, M W Whitehouse
Trends in Pharmacological Sciences|February 1, 1995
Targeting HIV-1 protease: a test of drug-design methodologiesM L West, D P Fairlie
Drug Design and Discovery|December 1, 1991
Transdermal delivery of inorganic complexes as metal drugs or nutritional supplementsD P Fairlie, M W Whitehouse
Current Opinion in Drug Discovery & Development|August 4, 2009
Macrocyclic peptidomimetics: potential for drug developmentR P McGeary, D P Fairlie
Pageof 8